Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 17, 2026 13:41 ET | Source: Eimskipafelag Islands hf.

Announcement from Eimskip: Seafarers’ Union of Iceland announces strike

Eimskip and Faroe Ship have received a notice from the Seafarers’ Union of Iceland (SÍ) announcing an indefinite strike by bosuns and able seamen on the Company’s own vessels Brúarfoss, Dettifoss, and...
May 17, 2026 13:41 ET | Source: Eimskipafelag Islands hf.

Tilkynning frá Eimskip: Sjómannafélag Íslands boðar verkfall

Eimskip og Faroe Ship hefur borist tilkynning um verkfallsboðun frá Sjómannafélagi Íslands (SÍ) þar sem boðað er ótímabundið verkfall bátsmanna og háseta á eigin skipum félagsins, þ.e. Brúarfossi,...
May 17, 2026 12:00 ET | Source: Publicis Groupe S.A

Publicis to acquire LiveRamp to accelerate data co-creation for smarter agents

Publicis to acquire LiveRamp to accelerate data co-creation for smarter agents The Groupe will expand its addressable market and raise its 2027-2028 financial objectives May 17, 2026 – Paris...
May 17, 2026 12:00 ET | Source: Publicis Groupe S.A.

Publicis acquiert LiveRamp pour accélérer la co-création de données au service d'agents plus intelligents

Publicis acquiert LiveRamp pour accélérer la co-création de données au service d'agents plus intelligents Le Groupe élargit son marché adressable et relève ses objectifs financiers 2027-2028 ...
May 17, 2026 10:15 ET | Source: Nanobiotix S.A.

Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer

PARIS and CAMBRIDGE, Mass., May 17, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic...
May 17, 2026 10:15 ET | Source: Nanobiotix S.A.

NANOBIOTIX ANNONCE LA PRÉSENTATION DE DONNÉES DE LA PREMIÉRE PARTIE DE L’ÉTUDE CLINIQUE RANDOMISÉE DE PHASE 2 EVALUANT JNJ-1900 (NBTXR3) DANS LES CANCERS DU POUMON DE STADE 3 INOPÉRABLE

PARIS et CAMBRIDGE, Mass., 17 mai 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO – NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique...
May 15, 2026 17:00 ET | Source: Anoto Group AB

Anoto publishes its annual report for 2025 and corrects for changes in the results as reported in the year-end report

Anoto Group AB (publ) ("Anoto") today publishes its annual report for 2025 and corrects for changes in the results as reported in the year-end report published on 27 February 2026. The annual report...
May 15, 2026 17:00 ET | Source: Anoto Group AB

Anoto Group AB (publ): Anoto publicerar sin årsredovisning för 2025 och korrigerar för förändringar i de resultat som rapporterades i bokslutskommunikén

Anoto Group AB (publ) ("Anoto") publicerar idag sin årsredovisning för 2025 och korrigerar för förändringar i de resultat som rapporterades i bokslutskommunikén som publicerades den 27 februari 2026....
May 15, 2026 16:05 ET | Source: Oculis Holding AG

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

ZUG, Switzerland, May 15, 2026 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting and settlement of RSUs previously granted to directors of the Company, the annual equity incentive...
May 15, 2026 15:19 ET | Source: GN Store Nord A/S

Trading in GN Store Nord shares by board members, executives and associated persons

GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial...